Article: RCT Hits Licensing Milestone for Essential Protein Expression Tool.

Business Editors/Health/Medical Writers

BIOWIRE2

TUCSON, Ariz.--(BUSINESS WIRE)--May 26, 2004

Research Corporation Technologies has 100 biotechnology and pharmaceutical companies licensed to use a versatile DNA sequence that enables a high level of protein expression in mammalian cells.

RCT's Gene eXpression Technologies (GXT) licensing program has licensed the bovine growth hormone polyadenylation (bgh-polyA) signal sequence to companies in the United States, Canada, Japan, Europe and Australia.

The bgh-polyA signal is a specialized termination sequence useful for producing pharmaceutical proteins and peptides in mammalian ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!